70520 Federal Register / Vol. 71, No. 233 / Tuesday, December 5, 2006 / Notices 

current certification process with the 

exception of the requirement ‘‘for nurse/ 

pharmacist certification through 

AAPCC.’’

From the comments received, there is 

consensus support for the AAPCC 

certification program. The guidelines by 

which the Secretary shall approve a 

professional organization and/or State 

government as having standards for 

certification will be that any 

certification program must meet or 

exceed current certification standards 

being used by AAPCC to certify PCCs. 

Send comments to Maxine Jones, 

HRSA, HSB, Division of Healthcare 

Preparedness, Healthcare Systems 

Bureau, Room 13–103, 5600 Fishers 

Lane, Rockville, MD 20857. Comments 

should be received within 60 days of 

this notice. 

Dated: November 28, 2006. 

Elizabeth M. Duke, 

Administrator. 

[FR Doc. E6–20564 Filed 12–4–06; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Second Annual Philip S. Chen, Jr. 

Distinguished Lecture on Innovation 

and Technology Transfer 

AGENCY: National Institutes of Health, 

Public Health Service, HHS. 

ACTION: Notice. 

SUMMARY: The Office of the Director, 

NIH, invites you to the second annual 

Philip S. Chen, Jr., Ph.D. Distinguished 

Lecture on Innovation and Technology 

Transfer. 

DATES: Friday, January 26, 2007, at 1 

p.m. 

ADDRESSES: NIH campus, 9000 

Rockville Pike, Bethesda MD, NIH 

Clinical Center (Building 10), Lipsett 

Auditorium. 

FOR FURTHER INFORMATION CONTACT: For 

additional information, sign language 

interpretation or accommodation for 

disabilities, please contact Colleen 

Crone at 301–496–1921 or 

cronec@od.nih.gov. 

SUPPLEMENTARY INFORMATION: Dr. 

Douglas R. Lowy will present ‘‘The 

Science, Technology and Promise of 

Preventive HPV Vaccines.’’ Dr. Lowy is 

Chief of the Basic Research Laboratory 

and the Laboratory of Cellular Oncology 

at the NCI Center for Cancer Research, 

where he also serves as deputy director. 

With colleagues at NIH, he developed 

the original technology on which the 

Merck HPV vaccine, Gardasil, is based. 

This annual series honors Dr. Philip 

S. Chen, Jr. for his almost 50 years of 

service to the National Institutes of 

Health. Dr. Chen established NIH’s 

Office of Technology Transfer in 1986 to 

implement the Federal Technology 

Transfer Act. The inventions in the 

Office of Technology Transfer’s 

intellectual property portfolio are 

crucial in advancing the NIH mission—

making important discoveries that 

improve health and save lives. 

Dated: November 27, 2006. 

Bonny Harbinger, 

Deputy Director, Office of Technology 

Transfer, National Institutes of Health. 

[FR Doc. E6–20577 Filed 12–4–06; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel, 

Research in Severe Asthma. 

Date: December 12, 2006. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Valerie L. Prenger, PhD, 

Health Scientist Administrator, Division of 

Extramural Affairs, National Heart, Lung, and 

Blood Institute, 6701 Rockledge Drive, MSC 

7924, Room 7214, Bethesda, MD 20892–7924, 

(301) 435–0270. prengerv@nhlbi.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: November 28, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9525 Filed 12–4–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, 

Development of State-of-the-Art Mechanisms 

for Epidemiological Research. 

Date: December 6, 2006. 

Time: 1:30 p.m. to 3 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6101 

Executive Boulevard, Rockville, MD 20852 

(Telephone Conference Call). 

Contact Person: Eric Zatman, Contract 

Review Specialist, Office of Extramural 

Affairs, National Institute on Drug Abuse, 

NIH, DHHS, Room 220, MSC 8401, 6101 

Executive Boulevard, Bethesda, MD 20892–

8401, (301) 435–1438. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, Develop 

a Real-Time fMRI Feedback System that 

Allows Drug Abusers to Control Cravings and 

Urges and/or Increase Their Self-Control of 

Their Drug Taking. 

Date: December 20, 2006. 

Time: 10 a.m. to 12 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6101 

Executive Boulevard, Rockville, MD 20852 

(Telephone Conference Call). 


ycherry on PROD1PC64 with NOTICES
Federal Register / Vol. 71, No. 233 / Tuesday, December 5, 2006 / Notices 70521 

Contact Person: Lyle Furr, Contract Review 

Specialist, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 220, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401, (301) 

435–1439, lf33c.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.279, Drug Abuse and 

Addiction Research Programs, National 

Institutes of Health, HHS) 

Dated: November 29, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9524 Filed 12–4–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Deafness and 

Other Communication Disorders; 

Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Deafness and Other 

Communication Disorders Advisory 

Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Deafness and 

Other Communication Disorders Advisory 

Council. 

Date: January 26, 2007. 

Closed: 8:30 a.m. to 10:45 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Bethesda, MD 

20892. 

Open: 10:45 a.m. to 2:30 p.m. 

Agenda: Staff reports on divisional, 

programmatic, and special activities. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Bethesda, MD 

20892. 

Contact Person: Craig A. Jordan, PhD, 

Director, Division of Extramural Activities, 

NIDCD, NIH, Executive Plaza South, Room 

400C, 6120 Executive Blvd., Bethesda, MD 

20892–7180, 301–496–8693, 

jordanc@nidcd.nih.gov. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.nidcd.nih.gov/about/groups/ndcdac/, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.173, Biological Research 

Related to Deafness and Communicative 

Disorders, National Institutes of Health, HHS) 

Dated: November 28, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9526 Filed 12–4–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; Clinical Trial Methods in 

Neurology. 

Date: December 14, 2006. 

Time: 8 a.m. to 3 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Westin Embassy Row, 2100 

Massachusetts Ave., NW., Washington, DC 

20008. 

Contact Person: Phillip F. Wiethorn, 

Scientific Review Administrator, DHHS/NIH/ 

NINDS/DER/SRB, 6001 Executive Boulevard; 

MSC 9529, Neuroscience Center; Room 3203, 

Bethesda, MD 20892–9529, (301) 496–5388. 

wiethorp@ninds.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: November 28, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9528 Filed 12–4–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel, Udall Centers Review. 

Date: December 7, 2006. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: W. Ernest Lyons, PhD, 

Scientific Review Administrator, Scientific 

Review Branch, NINDS/NIH/DHHS, 

Neuroscience Center, 6001 Executive Blvd., 

Suite 3208, MSC 9529, Bethesda, MD 20892–

9529. (301) 496–4056. 

This notice is being published less than 15 

days prior to the meeting due to the timing 


ycherry on PROD1PC64 with NOTICES